This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

This material (also included in the Prescriber guide) is provided to guide Healthcare professionals in monitoring the liver function of patients before and during treatment with Valdoxan. This material is a scheme detailing how the liver function of patients taking Valdoxan should be monitored.

A Patient Card must be provided to each patient who is prescribed Valdoxan and the Prescriber should explain the importance of the liver function monitoring to the patient.

This material has been developed to increase awareness about the recommendations for use for Valdoxan, in order to minimise the risk of serious liver adverse reactions. The Prescriber Guide includes guidance for Healthcare professionals in monitoring the liver function of patients before and during treatment with Valdoxan. If you require hard copy of the above materials or for further information, please contact Servier Medical Information (telephone: 01753 666409, email: [email protected])

This HCP guide is: Provided for HCPs to read before prescribing and administering Vanflyta A reminder to distribute a patient Card to any patient receiving Vanflyta treatment for the first time or if asked for a new copy

A reminder to distribute a patient Card to any patient receiving Vanflyta treatment for the first time or if asked for a new copy

Risk management materials for patients taking Vaxchora

Risk Management materials guide for HCPs

The prescriber checklist is intended to remind the prescriber of important potential risks associated with etrasimod use and recommended tests before and during treatment.

Patient card designed to enhance the awareness and knowledge of patients of childbearing potential about embryofoetal toxicity in pregnant females exposed to etrasimod and ensure the appropriate use of Velsipity.

The patient/caregiver guide is intended to enhance the awareness and knowledge of patients about etrasimod, including important safety information, and to ensure appropriate use of Velsipity.

Venclyxto Patient Card with safety information about Venclyxto for patients with Chronic Lymphocytic Leukaemia (CLL). This card contains information for the patient with regards to Tumour Lysis Syndrome and Venclyxto.

Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care.

This document contains essential information you will need to know and consider when assessing men as suitable candidates for use of VIAGRA connect. Such as understanding erectile dysfunction, who can use Viagra Connect, providing advice and patient supply/case study examples.

A 2 page optional guide to help pharmacists when assessing men’s suitability for using Viagra Connect

This Patient Alert Card is used to facilitate regular tracking and monitoring of hepatotoxicity and teratogenicity.

Healthcare Professional Checklist to be completed at each visit.

Patient Alert card.

Healthcare Professional Q&A Brochure

Question and Answer brochure intended for prescribers and other healthcare professionals involved in treatment with Voriconazole. The brochure covers important identified risks of Voriconazole and how they should be mitigated and managed

Checklist to be completed at each visit with patients being treated with Voriconazole. Each of the three sections include important risk information followed by a series of check boxes to help in the management of patients for whom Voriconazole is being prescribed.

Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care.

Checklist to be completed at each visit with patients being treated with Voriconazole. Each of the three sections include important risk information followed by a series of check boxes to help in the management of patients for whom voriconazole is being prescribed.

Question and Answer brochure intended for prescribers and other healthcare professionals involved in treatment with voriconazole. The brochure covers important identified risks of Voriconazole and how they should be mitigated and managed

Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care.

Voriconazole Patient Alert Card

Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care

Guide for Homecare Nurse, Patient, Caregiver 2023

Guide for Treating Physicians - 2023 Nov

Healthcare professional guide to highlight key information related to prescribing, management, monitoring and safety considerations included in the Risk Management Plan